Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique.
de Deus N, Capitine IPU, Bauhofer AFL, Marques S, Cassocera M, Chissaque A, Bero DM, Langa JP, Padama FM, Jeyaseelan V, Oberste MS, Estivariz CF, Verma H, Jani I, Mach O, Sutter RW.
de Deus N, et al. Among authors: jeyaseelan v.
J Infect Dis. 2022 Aug 24;226(2):292-298. doi: 10.1093/infdis/jiaa704.
J Infect Dis. 2022.
PMID: 33180924
Free PMC article.
Clinical Trial.